DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+3.05%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$15.4B
AUM Growth
+$758M
(+5.2%)
Cap. Flow
+$361M
Cap. Flow
% of AUM
2.35%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
1,277
New
124
Increased
437
Reduced
439
Closed
64
Top Buys
| 1 |
Cisco
CSCO
|
+$75.4M |
| 2 |
Merck
MRK
|
+$58.7M |
| 3 |
AT&T
T
|
+$48.4M |
| 4 |
Exxon Mobil
XOM
|
+$43.8M |
| 5 |
Duke Energy
DUK
|
+$40.4M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
+$130M |
| 2 |
Apple
AAPL
|
+$54.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$48.4M |
| 4 |
3M
MMM
|
+$44.6M |
| 5 |
Deutsche Bank
DB
|
+$31.6M |
Sector Composition
| 1 | Technology | 19.26% |
| 2 | Financials | 15.29% |
| 3 | Healthcare | 15.13% |
| 4 | Communication Services | 10.15% |
| 5 | Consumer Discretionary | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Omeros
OMER
$287M
| $351K | ﹤0.01% |
19,200
| – | – |
|
|
AGR
977
DELISTED
Avangrid, Inc.
AGR
| $350K | ﹤0.01% |
6,643
-11,522
| -63% | -$607K |
|
|
GHDX
978
DELISTED
Genomic Health, Inc.
GHDX
| $350K | ﹤0.01% |
7,000
-10,000
| -59% | -$500K |
|
979
CytomX Therapeutics
CTMX
$360M
| $345K | ﹤0.01% |
15,100
-12,000
| -44% | -$274K |
|
980
Karyopharm Therapeutics
KPTI
$54.2M
| $344K | ﹤0.01% |
1,353
| – | – |
|
|
SRCL
981
DELISTED
Stericycle Inc
SRCL
| $337K | ﹤0.01% |
4,847
-5
| -0.1% | -$348 |
|
982
Collegium Pharmaceutical
COLL
$1.19B
| $329K | ﹤0.01% |
13,500
| – | – |
|
983
Under Armour Class C
UA
$2.11B
| $328K | ﹤0.01% |
14,692
-13
| -0.1% | -$290 |
|
984
Atara Biotherapeutics
ATRA
$85.5M
| $325K | ﹤0.01% |
360
| – | – |
|
985
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $323K | ﹤0.01% |
21,900
| – | – |
|
986
Terex
TEX
$3.46B
| $323K | ﹤0.01% |
7,860
+2,830
| +56% | +$116K |
|
987
Cerus
CERS
$249M
| $320K | ﹤0.01% |
47,000
| – | – |
|
988
EastGroup Properties
EGP
$8.91B
| $317K | ﹤0.01% |
3,324
+1,782
| +116% | +$170K |
|
|
BIG
989
DELISTED
Big Lots, Inc.
BIG
| $317K | ﹤0.01% |
7,539
-5,700
| -43% | -$240K |
|
990
Ascendis Pharma
ASND
$12.4B
| $315K | ﹤0.01% |
4,800
-16,000
| -77% | -$1.05M |
|
991
Werner Enterprises
WERN
$1.71B
| $304K | ﹤0.01% |
+8,100
| New | +$304K |
|
|
SCG
992
DELISTED
Scana
SCG
| $303K | ﹤0.01% |
7,387
-13
| -0.2% | -$533 |
|
993
Semtech
SMTC
$5.26B
| $301K | ﹤0.01% |
6,400
-1,000
| -14% | -$47K |
|
|
SDRL
994
DELISTED
Seadrill Limited Common Stock
SDRL
| $300K | ﹤0.01% |
3,630
+2,614
| +257% | +$216K |
|
995
Amphastar Pharmaceuticals
AMPH
$1.36B
| $298K | ﹤0.01% |
19,200
| – | – |
|
996
Sabre
SABR
$686M
| $298K | ﹤0.01% |
11,126
+581
| +6% | +$15.6K |
|
|
ADAP
997
Adaptimmune Therapeutics
ADAP
$11.3M
| $294K | ﹤0.01% |
24,500
| – | – |
|
998
TEGNA Inc
TGNA
$3.38B
| $286K | ﹤0.01% |
25,884
-255,090
| -91% | -$2.82M |
|
999
Revvity
RVTY
$10B
| $284K | ﹤0.01% |
3,930
+2,230
| +131% | +$161K |
|
|
CCXI
1000
DELISTED
ChemoCentryx, Inc.
CCXI
| $280K | ﹤0.01% |
20,000
| – | – |
|